<?xml version="1.0" encoding="UTF-8"?>
<ref id="B23">
 <label>23.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Alvarado</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Ettayebi</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Atmar</surname>
    <given-names>RL</given-names>
   </name>
   <name>
    <surname>Bombardi</surname>
    <given-names>RG</given-names>
   </name>
   <name>
    <surname>Kose</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Estes</surname>
    <given-names>MK</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Human monoclonal antibodies that neutralize pandemic GII.4 noroviruses</article-title>. 
  <source>Gastroenterology</source>. (
  <year>2018</year>) 
  <volume>155</volume>:
  <fpage>1898</fpage>â€“
  <lpage>907</lpage>. 
  <pub-id pub-id-type="doi">10.1053/j.gastro.2018.08.039</pub-id>
  <?supplied-pmid 30170116?>
  <pub-id pub-id-type="pmid">30170116</pub-id>
 </mixed-citation>
</ref>
